In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

A GENOME-wide association study (GWAS) has identified 17 genetic loci linked to the risk of developing aortic stenosis (AS), ...

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...

The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.

For patients with asymptomatic severe aortic stenosis and myocardial fibrosis, early aortic valve intervention does ...

CHRISTUS Santa Rosa Hospital in New Braunfels is making a significant impact on heart health in the community with its Transcatheter Aortic Valve Replacement program.

Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and related challenge of timely patient access to lifesaving interventions such as ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

The trial was small and halted early, but investigators say the inflammatory hypothesis in TAVI is worth pursuing further.

“Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to guideline-recommended clinical surveillance in reducing the composite end point of ...

Fewer rehospitalizations and better functional and QoL outcomes point to TAVI as a good choice, but longer-term data are ...

The Company's Trilogy THV System is a TAVR system designed to treat patients with symptomatic, severe AR, and symptomatic, severe aortic stenosis who are at high surgical risk. The Trilogy THV System ...